Table 1.
Baseline demographic, clinical, and behavioral characteristics of study participants with and without incident CHD during follow-up (n = 555).
Variable | Total subcohort (n = 555) |
---|---|
Arsenic exposure TWA (μg/L-year) | |
1–20 | 428 (77) |
20–30 | 86 (15) |
30–45 | 33 (6) |
45–88 | 8 (1) |
Age (years, baseline) | 57 (46–64) |
Ethnicity | |
White non-Hispanic | 296 (53) |
Hispanic | 259 (47) |
Sex | |
Male | 267 (46) |
Female | 288 (54) |
Income | |
Low | 304 (47) |
High | 251 (53) |
First-degree family history of CHD | |
No | 439 (81) |
Yes | 116 (19) |
BMI (n = 1 missing) | 26.0 (23.7, 29.4) |
Diabetic (diagnosed at baseline visit) | |
No | 546 (98) |
Yes | 9 (2) |
Current smoker | |
Yes | 262 (48) |
No | 293 (52) |
Alcohol (g/week) | |
≤ 168 | 528 (95) |
> 168 | 27 (5) |
Water consumption (cups/day) | |
< 5 | 225 (39) |
≥ 5 | 330 (61) |
Physical activity | |
Sedentary | 367 (69) |
Active | 188 (31) |
Serum LDL (mg/dL) (n = 10 missing) | 134 (108, 163) |
Serum HDL (mg/dL) (n = 4 missing) | 46 (38, 56) |
Serum triglycerides (mg/dL) (n = 4 missing) | 145 (102, 197) |
Folate (mg) (dietary assessment estimate) | 257 (183, 137) |
Selenium (mg) (dietary assessment estimate) | 98 (89, 48) |
Values are n (%) or median (IQR). |